Disposable devices manufacturer Merit Medical Systems has received 510(k) clearance for its Corvocet biopsy system.

The system has been designed to collect core biopsy samples from the liver, kidney, prostate, breast, lung and various other soft tissue tumors.

Merit Medical Systems chairman and CEO Fred Lampropoulos said: "The Corvocet biopsy system is Merit’s first entry into the biopsy market and is the first of several biopsy devices we expect to introduce in the future.

"We believe the introduction of the Corvocet, a new line of One-Step™ Centesis Catheters, the SwiftNINJA steerable microcatheter, the Elation balloon dilator, and several other products slated for release will provide support for our projected growth and profit expectations for 2016 and beyond."

The company said that the device comes in stand-alone packaging and also as a component in certain kits to provide convenience for hospitals and physicians.

Corvocet biopsy system will be exhibited at the annual meeting of the Society of Interventional Radiology (SIR) in Vancouver, which will be held from 2 to 7 April.

Merit Medical manufactures and markets disposable medical devices used in interventional and diagnostic procedures, specifically in cardiology, radiology and endoscopy.